Among many other cases ACRI’s sister website “Holistic Justice” examined, a 2017 published analysis showed strong evidence that cytotoxic chemotherapy spreads breast cancer cells into the blood and body of the patient. (Source)
More recently another study confirmed that two commonly used breast cancer drugs promote lung metastasis. (Source)
While surgery alone can sometimes fix certain non-advanced cancers, the mainstream conventional standard of care is to reduce the size of the tumor via neoadjuvant chemotherapy before surgery.
But by doing this, the conventional oncologists puts in place a mechanism that will spur the cancer stem cells, inter alia, to mutate and spread. Furthermore, as this study shows, there is still another mechanisms by which cancer cells get reinforced.
Exoxomes with Unique Protein
In this study above, the researchers found that two chemotherapy drugs frequently used for patients, Taxol (paclitaxel) and Adriamycin (doxorubicin), induce breast cancer tumors to release tiny fluid filled sacs called exosomes, which contain a unique protein called annexin-A6 (ANXA6).
After being released from a chemotherapy-treated tumor, the exosomes circulate in the blood. When they reach the lungs, the exosomes release their content, including annexin-A6, which stimulates lung cells to release another protein, CCL2, which attracts immune cells called monocytes.
This immune reaction can be dangerous, as previous studies have shown that monocytes can actually help cancerous cells grow and survive in the lungs.
This is the negative entourage or negative feedback loop we have often talked about. Cancer cells are smart, they send signals to the immune system to be allies with cancer’s mission, total invasion of the host.
“In short, our study has identified a new link between chemotherapy and breast cancer metastasis” (Michele De Palma, lead scientist of Said Study)
Notwithstanding these findings, the study authors still recommend breast cancer patients undergo neoadjuvant chemotherapy as not all of the evidence is in, insofar as countering this new deleterious effect.
Appraisal & Tentative Conclusion
How could these researchers not recommend more chemo even by admitting that chemo kills. That’s where the money is, in selling more chemo. Furthermore, conventinal oncologists don’t get any training in nutritional oncology, let alone in hyperthermia and over 40 other scientifically proven efficient cancer modalities. The only factual conclusion that can be established by any reasonable mind is that most (not all, just most) of conventional oncology is either a fraud or quackery, or both, getting rich with a lethal misleading system when other credible options exist.
Pr. Joubert (ACR Institute)
Text under construction